Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Atrial fibrillation and chronic kidney disease

Research output: Contribution to journalEditorialResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{4a26a09f6fce4f18a14792e481c07242,
title = "Atrial fibrillation and chronic kidney disease",
abstract = "Atrial fibrillation and chronic kidney disease often co-exist and have shared risk factors. For this reason, the direction of the association between the two diseases is not clear. In a bidirectional Mendelian randomisation design, atrial fibrillation is causally related to a lower estimated glomerular filtration rate (eGFR) and a 6.1% higher risk of chronic kidney disease, while genetically predicted eGFR does not change the risk of atrial fibrillation.",
author = "Marianne Benn",
year = "2021",
month = aug,
day = "1",
doi = "10.1093/eurheartj/ehab301",
language = "English",
volume = "42",
pages = "2824--2826",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "29",

}

RIS

TY - JOUR

T1 - Atrial fibrillation and chronic kidney disease

AU - Benn, Marianne

PY - 2021/8/1

Y1 - 2021/8/1

N2 - Atrial fibrillation and chronic kidney disease often co-exist and have shared risk factors. For this reason, the direction of the association between the two diseases is not clear. In a bidirectional Mendelian randomisation design, atrial fibrillation is causally related to a lower estimated glomerular filtration rate (eGFR) and a 6.1% higher risk of chronic kidney disease, while genetically predicted eGFR does not change the risk of atrial fibrillation.

AB - Atrial fibrillation and chronic kidney disease often co-exist and have shared risk factors. For this reason, the direction of the association between the two diseases is not clear. In a bidirectional Mendelian randomisation design, atrial fibrillation is causally related to a lower estimated glomerular filtration rate (eGFR) and a 6.1% higher risk of chronic kidney disease, while genetically predicted eGFR does not change the risk of atrial fibrillation.

UR - http://www.scopus.com/inward/record.url?scp=85112168361&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehab301

DO - 10.1093/eurheartj/ehab301

M3 - Editorial

C2 - 34023873

VL - 42

SP - 2824

EP - 2826

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 29

ER -

ID: 67244114